Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.

Literature DB >> 6441624

Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.

J Pødenphant, C Christiansen, B D Catherwood, L J Deftos.

Abstract

We have evaluated serum bone Gla protein (BGP) changes in a double-blind study of early postmenopausal women during treatment with estrogen and calcium. To substantiate the changes in bone turnover, serum alkaline phosphatase, 24-hour urinary calcium, and bone mineral content (BMC) have also been measured. Our results indicate that serum BGP is a valuable measurement of bone metabolism.

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 1984 PMID： 6441624 DOI： 10.1007/bf02405361

Source DB: PubMed Journal: Calcif Tissue Int ISSN： 0171-967X Impact factor: 4.333

12 in total

1. Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone.

Authors: P A Price; J W Poser; N Raman
Journal: Proc Natl Acad Sci U S A Date: 1976-10 Impact factor: 11.205

2. The biosynthesis of collagen and its disorders (first of two parts).

Authors: D J Prockop; K I Kivirikko; L Tuderman; N A Guzman
Journal: N Engl J Med Date: 1979-07-05 Impact factor: 91.245

3. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.

Authors: C Christiansen; M S Christensen; I Transbøl
Journal: Lancet Date: 1981-02-28 Impact factor: 79.321

4. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

Authors: P A Price; M K Williamson; J W Lothringer
Journal: J Biol Chem Date: 1981-12-25 Impact factor: 5.157

5. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

Authors: C Christiansen; M S Christensen; P McNair; C Hagen; K E Stocklund; I Transbøl
Journal: Eur J Clin Invest Date: 1980-08 Impact factor: 4.686

6. Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3.

Authors: C M Gundberg; D E Cole; J B Lian; T M Reade; P M Gallop
Journal: J Clin Endocrinol Metab Date: 1983-05 Impact factor: 5.958

7. Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects.

Authors: B D Catherwood; R Marcus; P Madvig; A K Cheung
Journal: Bone Date: 1985 Impact factor: 4.398

8. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.

Authors: P A Price; J G Parthemore; L J Deftos
Journal: J Clin Invest Date: 1980-11 Impact factor: 14.808

7. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.

Authors: R Civitelli; D Agnusdei; P Nardi; F Zacchei; L V Avioli; C Gennari
Journal: Calcif Tissue Int Date: 1988-02 Impact factor: 4.333

7 in total

Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.

1. Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone.

2. The biosynthesis of collagen and its disorders (first of two parts).

3. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.

4. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

5. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

6. Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3.

7. Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects.

8. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.

9. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma.

10. Changes in plasma bone GLA protein during treatment of bone disease.

1. Oral contraception affects osteocalcin serum profiles in young women.

2. Serum bone Gla protein in streak gonad syndrome.

3. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression.

4. Evaluation of serum osteocalcin as an index of altered bone metabolism.

5. Biochemical short-term changes produced by hormonal replacement therapy.

6. [Osteocalcin and bone histology in osteoporosis].

7. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.